Key result
Unenhanced CT using a 10 H threshold followed by MR imaging was the most cost-effective strategy for evaluating an adrenal mass in newly diagnosed non-small cell lung cancer (ICER $16,370/LYG).
Why the study?
What is the most cost-effective strategy for evaluating an adrenal mass in a patient with newly diagnosed non-small cell lung cancer?
What is the most cost-effective strategy for evaluating an adrenal mass in a patient with newly diagnosed non-small cell lung cancer?
Effect estimate: ICER $16,370 per year of life gained
Unenhanced CT using a 10 H threshold followed by MR imaging is the most cost-effective strategy for evaluating adrenal masses in patients with newly diagnosed non-small cell lung cancer.
Authors
No takes yet. Share an insight, caveat, or question.
May support CT (10 H) plus MR as cost-effective for adrenal masses in new NSCLC; leaves open prospective validation before practice change.
Remer et al. (2000) studied Non-small cell lung carcinoma with adrenal mass. Unenhanced CT using a 10 H threshold followed by MR imaging vs. CT with a threshold of 0 H followed by biopsy was evaluated on Cost-effectiveness (incremental cost-effectiveness ratio) (ICER $16,370 per year of life gained). Unenhanced CT using a 10 H threshold followed by MR imaging was the most cost-effective strategy for evaluating an adrenal mass in newly diagnosed non-small cell lung cancer (ICER $16,370/LYG).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: